Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles.
Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles.
复制标题
DOI:
10.1371/journal.pone.0265852
复制
发表时间:
2022
期刊:
影响因子:
3.7
通讯作者:
Gelfand EW
中科院分区:
文献类型:
--
作者:
Abbott JK;Chan SK;MacBeth M;Crooks JL;Hancock C;Knight V;Gelfand EW
Despite adequate infection prophylaxis, variation in self-reported quality of life (QOL) throughout the intravenous immunoglobulin (IVIG) infusion cycle is a widely reported but infrequently studied phenomenon. To better understand this phenomenon, subjects with humoral immunodeficiency receiving replacement doses of IVIG were studied over 3 infusion cycles. Questionnaire data from 6 time points spread over 3 IVIG infusions cycles (infusion day and 7 days after each infusion) were collected in conjunction with monitoring the blood for number of regulatory T-cells (Treg) and levels of 40 secreted analytes: primarily cytokines, chemokines, and growth factors. At day 7, self-reported well-being increased, and self-reported fatigue decreased, reflecting an overall improvement in QOL 7 days after infusion. Over the same period, percentage of Treg cells in the blood increased (p<0.01). Multiple inflammatory chemokine and cytokine levels increased in the blood by 1 hour after infusion (CCL4 (MIP-1b), CCL3 (MIP-1a), CCL2 (MCP-1), TNF-α, granzyme B, IL-10, IL-1RA, IL-8, IL-6, GM-CSF, and IFN- γ). The largest changes in analytes occurred in subjects initiated on IVIG during the study. A significant decrease in IL-25 (IL-17E) following infusion was seen in most intervals among subjects already receiving regular infusions prior to study entry. These findings reveal several short-term effects of IVIG given in replacement doses to patients with humoral immunodeficiency: QOL consistently improves in the first week of infusion, levels of a collection of monocyte-associated cytokines increase immediately after infusion whereas IL-25 levels decrease, and Treg levels increase. Moreover, patients that are new to IVIG experience more significant fluctuations in cytokine levels than those receiving it regularly.
登录
查看更多内容
DOI:
10.1111/j.2517-6161.1995.tb02031.x
发表时间:
1995-01-01
影响因子:
5.8
作者:
BENJAMINI, Y;HOCHBERG, Y
通讯作者:
HOCHBERG, Y
DOI:
10.1084/jem.20140039
发表时间:
2014-09-22
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Perreau M;Vigano S;Bellanger F;Pellaton C;Buss G;Comte D;Roger T;Lacabaratz C;Bart PA;Levy Y;Pantaleo G
通讯作者:
Pantaleo G
影响因子:
7.3
作者:
Quinti, Isabella;Mitrevski, Milica
通讯作者:
Mitrevski, Milica
影响因子:
24.1
作者:
Maddur, Mohan S.;Trinath, Jamma;Bayry, Jagadeesh
通讯作者:
Bayry, Jagadeesh
影响因子:
5.8
作者:
Bates, Douglas;Maechler, Martin;Walker, Steven C.
通讯作者:
Walker, Steven C.